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Induction  of immunological unresponsiveness in  lymphoid cells has been experi- 
mentally accomplished in a  variety of ways both in vivo and in vitro (1-3). The ease 
of establishment  of tolerance  depends  on  several  factors,  including  maturity  and 
immunological  status  of the  lymphoid  cells.  It  is  well  established  that  neonatal 
lymphoid cells are more readily tolerized than  are adult  cells  (1-7)  and  unprimed, 
virgin lymphoid cells are more susceptible to tolerance induction  than primed cells 
(1, 8, 9). Nevertheless, under selected conditions, immunological tolerance using adult 
lymphoid cells, both primed (8, 9) and unprimed (4-7, 10-12), has been demonstrated. 
There is evidence that the restrictions to tolerizing adult spleen cells are related to the 
isotype of their surface immunoglobulin (Ig) receptors. The majority of adult, murine 
splenic B cells bear IgD as one of their surface Ig receptors, whereas neonatal splenic 
B cells predominantly bear IgM without  IgD (13), which suggests that the presence 
of IgD interferes with tolerance induction.  This is supported by the observation that 
removal or masking of surface IgD on adult spleen cells facilitates tolerance induction 
in vitro, with lesser amounts of tolerogen capable of inducing tolerance than would 
otherwise be required  (14-16). 
The difficulty in tolerizing primed spleen cells as compared with unprimed spleen 
cells has not  been  extensively investigated,  but  several studies  have suggested  that 
primed spleen cells can be made unresponsive.  Mice  primed with  human  gamma- 
globulin  (HGG)  x can be made tolerant to HGG by a series of injections of relatively 
large amounts of soluble HGG (8).  On the other hand, HGG-primed B cells can be 
tolerized to HGG in vivo as effectively as nonprimed B cells when primed splenic T 
cells  are  removed  before  tolerance  induction  (9).  Similarly,  Katz  et  al.  (17)  have 
shown that hapten-primed B cells can be made unresponsive by exposure to hapten- 
ated conjugates that are unrelated  to carriers used in priming, or by use of hapten- 
conjugated,  nonimmunogenic carriers.  Both conjugates avoid primed T  cells. Thus, 
the problem of tolerizing primed spleen cells may be avoided if primed T  cells are 
circumvented in some manner. 
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The present report describes in vitro tolerance induction of spleen cells from mice 
primed with trinitrophenylated keyhole limpet hemocyanin (TNP-KLH), by methods 
similar to those used to tolerize nonprimed spleen cells in vitro. The data show that 
primed  spleen  cells  can  be  made  specifically  unresponsive  by  addition  of  TNP 
conjugated to a  carrier that  is antigenically unrelated to the KLH  used in priming, 
with unresponsiveness stable upon the removal of the conjugate by multiple washes, 
which  indicates the  induction  of a  tolerant  state.  Furthermore, examination  of the 
surface isotype of the B  cells susceptible to  tolerance induction  suggests  that  IgG  +, 
IgD- B cells are the target cells for tolerance induction. The significance of a tolerance 
model using primed, potentially IgG-secreting spleen cells in the further examination 
of the role of IgD in tolerance induction is discussed. 
Materials  and  Methods 
Mice and Immunizations.  A/J male mice from The Jackson Laboratory, Bar Harbor, Maine, 
were immunized intraperitoneally with 100-200 #g TNP-KLH in complete Freund's adjuvant 
at 9-10 wk of age (18). 
TNP Conjugates.  KLH was prepared as described and haptenated at 10 groups/100,000 mol 
wt (18). Turkey gammaglobulin (TGG) (19) and ovalbumin (OVA) (Miles Laboratories, Inc., 
Elhart, Ind.) were conjugated at a ratio of 10 and 20 TNP groups/molecule, respectively. The 
conjugates were sterilized by filtration (0.22/zm pore size) and stored at 4°(3. 
Generation and Assay of Antibody-producing Cells.  Spleen cells from  mice primed with TNP- 
KLH and boosted intraperitoneally with 20/~g soluble TNP-KLH were cultured 14-22 d later 
in microtiter plates in minimum essential medium containing 7.5% fetal calf serum (FCS), 2- 
mercaptoethanol  (5  ×  10  -5 M),  and  nutrient  and  antibiotic additions (18).  TNP-KLH  was 
added at a  final concentration of 0.005/~g/ml.  Indirect (IgG) plaque-forming cells (PFC) to 
TNP were measured against TNP-coupled burro erythrocytes 4-5 d  later (18).  Indirect PFC 
were developed using a  sheep anti-mouse Ig serum that  prevented the development of IgM 
PFC by >  75%. Only indirect PFC were measured in this study because the IgM response was 
routinely 20% or less than that of the IgG response. Results are expressed as the mean with 
standard deviation (SD) of duplicate cultures; PFC were normalized per l0  T input spleen cells. 
Induction of Unresponsiveness.  Unresponsiveness to  TNP-KLH  was  induced  in  spleen cells 
from  mice  primed  and  boosted  to  TNP-KLH  either  by  adding  soluble  TNP  conjugates 
simultaneously with the addition of TNP-KLH to the spleen cell cultures, or by preincubating 
thespleen cells with the conjugates, followed by extensive washing before addition of TNP- 
KLH, carried out as follows. Spleen cells were cultured at 4 ×  10S/ml per culture well of a 24- 
hole plate (3008,  Falcon Labware, Div. of Becton, Dickinson and Co., Oxnard, Calif.) for 1 h 
at 37°C, at which time TNP-TGG was added. After 20 h culture at 37°C, the cells were washed 
three times with phosphate-buffered saline (PBS)  (18)  containing 5% FCS. To minimize the 
transfer of TNP-TGG by macrophages and also to aid in recovery of cells from the plastic after 
20 h incubation, the number of plastic-adherent cells was reduced by adsorbing 30 ×  108 spleen 
cells at 37°C in 5 ml medium per 100-mm Diam culture dish (Falcon Labware). After 30 rain, 
nonadherent  cells were  collected by  vigorous  pipetting.  This  process  depleted  nonspecific 
esterase-staining cells by ~50% and had no inhibitory effect on the response to TNP-KLH. The 
adherence procedure was not necessary for induction of unresponsiveness, but was used for the 
technical purposes outlined above. 
Removal of Various Ig-bearing Cells.  IgM-, IgD-, and  IgGa-bearing B cells were depleted by 
physical adherence to glutaraldehyde-fixed, tanned  sheep erythrocytes (RBC)  coupled with 
antisera specific for the respective heavy chain determinants and removal of RBC-lymphoid 
cell aggregates, or rosettes, on a  Ficoll-Isopaque gradient (18).  Preparation and specificity of 
the  IgM  reagent  has  been  described  (18).  The  anti-IgD  rosetting  reagent  used  was  an 
immunoadsorbent  purified  rabbit  anti-mouse  IgD  antiserum  (13),  which  was  generously 
supplied by Dr. Ellen Vitetta, University of Texas Southwestern Medical School, Dallas, Tex. 
Goat anti-mouse !gGl was supplied by Dr.  Hans  Spiegelberg, Scripps Clinic and  Research 
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restricted to the heavy chain. The capacity of anti-IgM- and anti-IgD-coupled RBC reagents 
to deplete their respective B cell subpopulations was assessed using fluoresceinated anti-IgM 
and anti-IgD [F(ab)~ preparations]. Approximately 50% of the spleen cells were IgM  + and 55% 
were IgD  + as assessed by fluorescence microscopy. After depletion with anti-IgM or anti-IgD 
coupled RBC, respective B cell subpopulations were reduced to <  1%. All Ig-bearing cells were 
depleted with RBC coupled with a multispecific goat anti-mouse Fab antiserum (18). 
Depletion of Ly 2.2 Cells.  Spleen cells at 50 ×  106/ml were incubated at 4°C for 30 min with 
anti-Lye 2.2 serum obtained from Dr. F. W. Shen, Memorial Sloan-Kettering Cancer Center, 
New York. The cells were then washed twice with PBS/5% FCS and incubated at 37°C for 30 
rain in minimum essential medium containing 0.1% sodium azide and rabbit:guinea pig serum 
(1:2)  as a  source of complement. The complement had been adsorbed previously on  mouse 
tissues to avoid toxicity. 
Results 
Effect  of the  Presence of TNP-TGG on the  Secondary In  Vitro Antibody Response  to  TNP- 
KLH.  Spleen  cells from  mice primed and  boosted with  TNP-KLH  were cultured 
with TNP-KLH  and various amounts of soluble TNP-TGG  to determine the effect of 
TNP  coupled  to an  unrelated carrier on  the generation of PFC  to TNP  over a  4-d 
culture interval. The first experiment in Table I shows that TNP-TGG  was inhibitory, 
with 0.1  /.tg/ml and  1 #g/ml  causing 40  and  77%  suppression of the  PFC  response, 
respectively. In addition, suppression was dependent upon the hapten, TNP, as shown 
by the failure of nonhaptenated TGG to be suppressive (experiment 2, Table I). 
Effect of TNP-TGG on the Kinetic Response  to  TNP-KLH.  Antibody-producing cells 
in the previous experiments were measured on day 4, a  day previously determined as 
optimal  for  the  IgG  response  to  TNP-KLH  in  vitro.  To  determine  whether  the 
addition of TNP-TGG  might be inducing a  shift in antibody synthesis, the antibody 
response  with  and  without  TNP-TGG  present  was  measured  on  various  days  of 
culture. Fig. 1 shows that the response to TNP-KLH  without TNP-TGG  rose sharply 
between days 3 and 4, peaked on days 4  and 5, and began to fall by day 6. Cultures 
containing TNP-TGG  were markedly suppressed whether PFC were measured on day 
4, 5, or 6. Thus, suppression by TNP-TGG  was not due to a shift in antibody synthesis, 
but rather to a  suppression of the generation of antibody-producing cells. 
TABLE  I 
Effect of TNP-TGG on the Secondary In  Vitro Antibody Response to TNP- 
KLH* 
Percent sup-  Experiment  Addition  PFC ± SD  pression 
#g/ml 
None  27,346 ± 5,729  -- 
TNP-TGG O.01)  27,599 ±  716  0 
TNP-TGG (0.1)  16,548 ±  1,790  40 
TNP-TGG (1)  6,330 ± 3,581  77 
None  107,760 ± 31,220  -- 
TNP-TGG (1)  680 ± 509  100 
TGG (1)  112,000 ± 27,627  0 
* Spleen cells from mice primed and boosted with TNP-KLH were incubated 
with  TNP-KLH  antigen and soluble  TNP-TGG  or TGG.  After 4  d  of 
culture, IgG PFC to TNP were measured. Background PFC were <500 in all 








Day  of  Assay 
Fzc.  1.  Kinetics of the secondary response of TNP-KLH-primed and boosted spleen cells with and 
without TNP conjugate. Spleen cells with and without TNP-TGG (1/~g/ml) added simultaneously 
with TNP-KLH  were cultured for various time periods and  IgG  PFC  to TNP  were  measured. 
Background PFC were <14-0 on all d. O, without TNP-TGG; O, with TNP-TGG. 
TABLE  II 
Determination of the Effect of Time of Addition of TNP Conjugate to TNP- 
KLH Primed and Boosted Spleen Cell Cultures * 
Experiment  TNP Conju-  Time ofad-  PFC +  SD  Percent sup- 
gate  dition  pression 
2§ 
hY 
-  --  23,940 +  8,910  -- 
+  0  6,854 +  213  71 
+  20  26,059 +  1,280  0 
-  --  12,148 +  1,499  -- 
+  0  <72  100 
+  1  968 ±  862  92 
+  4  12,900+ 0  0 
* Spleen cells were incubated with TNP-KLH  antigen and TNP conjugates 
added either at 0 time or at various times thereafter at a concentration of 1 
/xg/ml. After 4 d of culture, IgG PFC to TNP were measured. Background 
PFC were <500 in all cases. 
TNP-TGG conjugate. 
§ TNP-OVA conjugate. 
Effect  of the  Time of Addition  of TNP Conjugate.  TNP  conjugate  was  added  either 
simultaneously  with  the  addition  of  TNP-KLH  or  at  various  times  thereafter  to 
determine  the phase  of the antibody  response  inhibited  by the conjugate.  The  first 
experiment  in Table  II shows that TNP-TGG  added  at culture  initiation with TNP- 
KLH  resulted  in  71% suppression.  However,  if TNP-TGG  was added  20 h  later,  the 
response was not suppressed.  To determine  more precisely when  TNP  conjugate  had 
to be added  to be suppressive, TNP  conjugate  was added  at 0,  1, and  4  h  after TNP- 
KLH.  The  second experiment  in Table  II shows that TNP-OVA  added  at 0  and  1 h 
was  highly  suppressive,  whereas  addition  4  h  after TNP-KLH  was  not  suppressive. 
TNP-OVA  conjugate  suppressed  responses  in  a  manner  similar  to  TNP-TGG,  al- 
though  TNP-TGG  was used in most experiments  reported  here. 
Effect of Preincubation  of Spleen  Cells  with  TNP-TGG.  The  fact  that  suppression  by SHARYN  M.  WALKER  AND  WILLIAM  O.  WEIGLE  657 
TNP conjugates could only be induced early in the antibody response suggested that 
inhibition entailed more than simple competition between TNP-KLH antigen and 
TNP conjugate for hapten-specific B cells, interfering with specific T-B cell coopera- 
tion.  Rather,  the data suggested that exposure of primed  spleen cells early in  the 
immune  response  to  the  hapten-conjugate  resulted  in  their  inactivation,  and  the 
presence  of soluble  TNP  conjugate  was  no  longer  required  for  suppression.  To 
determine whether this was the case, spleen cells were preincubated with TNP-TGG 
and  then  washed  extensively before culture  with  TNP-KLH  and  compared  with 
conjugate preincubated  cells  that  had  not  been  washed  free of soluble conjugate 
before addition of TNP-KLH. Table III shows that culture of the primed spleen cells 
for 20 h with 0.1 #g/ml TNP-TGG before the addition of TNP-KLH suppressed the 
PFC response by 90%  (group C), whereas preincubation with  10-fold lesser amount, 
0.01 #g/ml, was not suppressive (group B). Preincubation with 0.1 #g/ml TNP-TGG, 
followed by extensive washing before recuhure and addition of TNP-KLH, resulted 
in 83% suppression (group E), as effective as when TNP-TGG was continually present 
(group C). PFC were measured 5 d after TNP-KLH addition, rather than the usual 
4 d, to give the suppressed cells more opportunity to respond. Because the continual 
presence of 0.01 #g/ml TNP-TGG was not suppressive (group B), it is unlikely that 
suppression by preincubation with 0.1 #g/ml followed by extensive washing was due 
to transfer of suppressible amounts of soluble TNP-TGG.  Furthermore, the second 
experiment in the table shows that preincubation of spleen cells in the cold, followed 
by washing, did not result in suppression (group G), whereas the continual presence 
of TNP-TGG was suppressive (group H). Thus, failure to suppress by preincubating 
cells at 4°C followed by washing showed that the procedure itself was sufficient to 
remove soluble TNP-TGG and, moreover, suggested that the process of induction of 
TABLE III 
In Vitro Induction of Unresponsiveness to TNP-KLH by Preincubation of TNP-KLH 
Pnmed and Boosted Spleen Cells with TNP Conjugate 
Percent 
Treatment of spleen cells before  Experi-  Group  PFC ±  SD*  suppres- 
ment  addition of TNP-KLH  sion 
1  A  Culture 20 h  38,760  ±  1,075  -- 
B  Culture 20 h with TNP-TGG:[:  40,800  ±  5,280  0 
C  Culture 20 h with TNP-TGG§  3,927  ±  1,612  90 
D  Culture 20 h, wash, reculture  16,467 ±  1,791  -- 
E  Culture 20 h with TNP-TGG§,  2,755  ±  134  8311 
wash, reculture 
F  None  26,592  ±  5,363  -- 
G  4°C, 60 min with TNP-TGG¶,  31,667  ±  1,791  0 
wash 
H  None, TNP-TGG§ present  2,470  ±  986  91"* 
throughout culture 
* IgG PFC to TNP were measured 5 d after addition of TNP-KLH. 
:l: 0.01 #g/ml. 
§ O. 1 #g/ml. 
II Suppression was calculated relative to group D. 
¶ 1 ~g/ml. 
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unresponsiveness  with  TNP-TGG  involved  a  relatively rapid,  energy-dependent, 
direct  inactivation of the  primed  spleen  cells,  which  prevented  their  subsequent 
response  to TNP-KLH. Thus, tolerance, for at least a short period, appeared to be 
induced by preincubation with the conjugate at 37°C. 
Determination  of Whether Suppressor Cells are Involved in Tolerance Induction.  Spleen cells 
from  mice primed  and  boosted  with TNP-KLH  were depleted  of suppressor  T  cells 
with  anti-Ly  2.2  serum  and  complement  before culture  to  determine  their  possible 
role  in  tolerance  induction.  Table  IV shows  that  depletion  of the  suppressor  T  cell 
population  did  not  abrogate  the  capacity  of TNP-TGG  to  inhibit  the  response  to 
TNP-KLH. 
An alternative procedure  used was the mixing of tolerized and  nontolerized spleen 
cells to  determine  whether  the  tolerized cells inhibited  the  antibody  response  of the 
latter.  Spleen  cells  from  primed  and  boosted  mice  were  tolerized  by  preincubation 
with  TNP-TGG  for  20  h,  as  described  previously  in  Table  III,  washed,  and  then 
added  to  primed  and  boosted  spleen  cells that  had  not  been  incubated  with  TNP- 
TGG.  Table V  shows that  preincubation  of the spleen cells with TNP-TGG  tolerized 
the spleen cells (i.e., reduced  the response to TNP-KLH  from 48,703  to  11,702  PFC), 
but  mixing tolerized and  untreated  spleen  cells did  not  suppress  the capacity  of the 
latter  to  respond  to  TNP-KLH.  Thus,  tolerization  probably  results  from  a  direct 
inactivation  of specific  B  cells occurring  within  a  20-h  interval  of incubation  with 
tolerogen, with suppressor  cells not  involved in tolerance induction. 
TABLE  IV 
Failure of Removal of Suppressor T Cells to Abrogate Suppression with TNP- 
TGG Conjugate  * 
Percent sup-  Treatment  TNP-TGG  PFC ±  SD  pression 
None  -  118,613 3= 1,478  -- 
None  +  14,820 3= 1,347  88 
Anti-Ly 2.2 +  C  -  119,040 3= 7,680  -- 
Anti-Ly 2.2 +  C  +  16,000 3= 3,730  87 
• Spleen cells from mice primed and boosted with TNP-KLH were depleted 
of suppressor T cells by treatment with anti-Ly 2.2 + C before culture. TNP- 
TGG (0.1/~g/ml)  was added at culture initiation with TNP-KLH. IgG PFC 
to TNP were measured after 4 d. 
TABLE V 
Effect of Tolerized Spleen Cells on the Response of Nontolerized Spleen Cells * 
Spleen cell  Cell number/culture  PFC +  SD 
preparation 
X  10 -5 
Untreated  5  48,703 +  894 
Tolerized  5  11,702 3= 1,341 
Untreated +  tolerized  2.5 +  2.5  41,829 +  3,444 
* Spleen cells from mice primed and boosted  with TNP-KLH were cultured 
for  20  h  with  and  without  TNP-TGG  at  0.3  /tg/ml, washed,  and  then 
recultured with TNP-KLH separately or mixed together.  IgG PFC to TNP 
were measured 4 d  later.  The theoretical PFC value if no suppression  was 
exhibited is 30,202  (i.e., half the PFC response  of the untreated cells alone 
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Assessment  of  the  Role  of  IgD-bearing  Cells  in  the  Secondary  Response  to  TNP- 
KLH.  Because  the surface isotype of spleen cells has  been  implicated in  tolerance 
induction, and the presence of surface IgD makes cells more difficult to tolerize, it was 
investigated whether the relative ease in tolerizing primed spleen cells observed here 
correlated with a  lack of surface IgD on the TNP-primed, specific splenic B  cells. As 
stated previously (see Materials and Methods), the antibody response to TNP-KLH 
that  is generated  by spleen cells from  mice primed and  boosted with TNP-KLH  is 
predominantly an amplified, indirect antibody response with a relatively insignificant 
IgM component.  The latter is >75%  suppressed by the amplifier antiserum  used  in 
the plaquing procedure. Thus,  to determine whether the precursors of this predomi- 
nantly IgG response to TNP bore surface IgD, the spleen cells were depleted of surface 
IgD  +  cells and  the  subsequent  antibody response  was  measured.  Spleen  cells were 
depleted of IgD-bearing cells by physical adherence to RBC coated with heavy chain 
specific rabbit anti-mouse IgD serum and removing the lymphoid-RBC conjugates or 
rosettes on a density gradient. The depleted cells were then cultured with TNP-KLH, 
and antibody generation was measured 4  d  later. Table VI shows  that  depletion of 
99% of the IgD  + spleen cells, as assessed by fluorescence microscopy before and after 
depletion  (see Materials and  Methods),  did not  reduce  the response  to  TNP.  This 
failure to deplete potential antibody-producing cells occurs in spite of the fact that 
the majority of the splenic B  cells were removed (>90% as defined by elimination of 
bacterial  endotoxin-induced  mitogenesis  and  the  large  number  (-60%)  of B  cells 
forming rosettes with the reagent). 
TABLE VI 
Role of Cells Bearing IgD Receptors in the Secondary In Vitro Antibody 
Response to TNP-KLH* 
Experiment  Treatment before culture  PFC + SD 
1  None  100,040 +  14,086 
Depleted of IgD  ÷ cells:[:  166,400 :t: 18,102 
2  None  59,533 +  12,538 
Depleted of IgM  + cells§  88,667 :lz 14,329 
3  None  62,574 :t: 2,508 
Depleted of IgM  + and IgD  + cells  118,623  3= 4,049 
4  None  41,769 +  1,755 
Depleted ofIg  + cells  4,491 2:2,773 
5  None  17,010 + 2,673 
Depleted of IgG1  + cells  2,121:1:964 
* Primed cells were depleted of spleen cells bearing various surface Ig isotypes 
by physical adherence to RBC coupled with specific antisera and removing 
the lymphoid cells with adherent RBC on a Ficoll-Isopaque gradient. When 
both anti-IgM and anti-IgD depletions were done (experiment 3), the lgM  + 
cells were depleted first, followed by depletion of IgD  + cells. The IgG PFC: 
response to TNP was measured after 4 d of culture with TNP-KLH. 
:~ This procedure reduces the proliferative response to bacterial endotoxin by 
>90%. Also, ~60% of the spleen cells form rosettes with the anti-IgD coupled 
RBC and IgD-bearing cells are reduced 99% as assessed by immunofluores- 
cence. 
§ This procedure  eliminates  the secondary IgM response to TNP by ~'99% 
(18). Also, -55% of the spleen cells form rosettes with the anti-IgM coupled 
RBC, and IgM-bearing cells are reduced 99% as assessed by immunofluores- 
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To determine the isotype of the precursor cells of the antibody response, depletion 
experiments  were  done  with  other  class-specific  antisera.  Experiments  2  and  3  in 
Table VI show that  removal of IgM  + cells,  or both  IgD  + and  IgM  ÷ cells,  did  not 
reduce the response to TNP. Depletion of IgM-bearing cells has been shown previously 
to prevent total generation of the secondary IgM response to TNP by these primed 
and  boosted spleen  cells  (18).  Depletion  of IgM  ÷ or IgD  + cells  or both  resulted  in 
increased PFC responses, which probably reflects enrichment of TNP-specific B cells, 
as would be expected upon depletion of the bulk of splenic B cells  by the rosetting 
procedure.  Although  the  antibody  response  was  not  derived  from  IgD  or  IgM 
precursor cells,  it  was derived  from Ig-bearing cells,  as shown by depletion  with  a 
multispecific anti-mouse Ig reagent that reduced the subsequent  PFC response from 
41,769  to  4,491  (experiment  4,  Table  VI).  Furthermore,  the  Ig-bearing cells  were 
predominantly of the IgG class, as shown by the capacity of anti-IgG1 subclass-specific 
antisera-coupled RBC to deplete subsequent antibody-producing cells by 88% (exper- 
iment 5, Table VI). 
It should be noted that the variation in the magnitude of the antibody response to 
TNP-KLH which can be observed in  the five experiments  shown in Table VI and 
throughtout this study is typical of the response of spleen cells from mice primed and 
boosted with TNP-KLH. The reasons for this variation are not known, but mouse to 
mouse variation, the length of time after priming, and/or less than optimal in vitro 
eliciting antigen  concentration may be contributing factors. To investigate  the last 
possibility, the effect of depleting IgD  + or IgM  + cells was measured using spleen cells 
cultured with a  range of concentrations of TNP-KLH to ensure that IgD  ÷ or IgM  + 
cells  were not involved at essentially all  the eliciting antigen concentrations. It was 
found  that  at  no  concentration  of TNP-KLH,  suboptimal  or  supraoptimal,  did 
depletion of IgD  + or IgM  + cells  reduce the antibody response (data not shown). 
The surface Ig isotype of the spleen cells involved in the antibody response to TNP- 
KLH was also assessed  by blocking with isotype-specific antisera added directly to the 
spleen  cell  cultures.  The  antisera  used  were  the  same  immunoadsorbent  purified 
antisera to IgM, IgD, and IgG that were used in the depletion experiments described 
in Table VI. Table VII shows that only anti-IgG1 blocked the antibody response, and 
anti-IgM and anti-IgD had no inhibitory effect. Thus, both the negative selection of 
isotype-speeific B cells  (Table VI) and the blocking with specific antisera (Table VII) 
TABLE VII 
Inhibition of the Indirect, Secondary Antibody Response to TNP-KLH with 
Anti-IgG, but Not Anti-lgD or Anti-lgM 
Antiserum added at culture initiation*  Percent inhibition of indirect 
PFC 
Anti-IgD  0 
Anti-lgM  0 
Anti-IgG1  90 
* Immunoadsorbent purified antisera to IgD, IgM, and IgGl were added at 10 
/~g/ml to cultures of spleen cells from mice primed and boosted with TNP- 
KLH. After 4 d,  the  indirect antibody response to TNP was measured. 
Inhibition of the response by antisera was measured relative to the control 
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indicate that the B cells that are responsible for the antibody response and are thus 
susceptible to tolerance induction are IgD-, IgM-, and IgG  ÷ B cells. 
Discussion 
The above results demonstrate that primed spleen cells can be made unresponsive 
in vitro by using a  tolerization protocol that  involves preincubation with tolerogen 
followed by extensive washing and is similar to protocols used to tolerize nonprimed 
spleen cells (4-7). Tolerance was probably facilitated by the circumvention of primed 
T  cells by using,  as  tolerogen, a  haptenated-carrier complex not  used  in  priming. 
Other research has shown that  tolerance induction in nonprimed B cells cannot be 
established if T  cells primed to the tolerogen are present (3, 4, 9). Excessive amounts 
of tolerogen  were  not  required,  0.1  #g  TNP-TGG/ml  being  adequate,  which  is 
significantly  less  than  that  used  in  most  nonprimed  tolerance  models  with  adult 
spleen cells (4-7). The small amount of tolerogen required for unresponsiveness may 
be due to the fact that primed B cells were used instead of nonprimed cells.  Primed 
cells usually have higher avidity receptors for antigen and lesser amounts of surface 
Ig  (20),  factors  that  may  make  it  easier  to  saturate  their  surface  receptors  with 
tolerogen to initiate the tolerance process. It is well established that tolerance is more 
easily achieved with high than low avidity antibody precursor cells (21). Furthermore, 
the surface isotype of the B cells being tolerized was shown to be IgG only, without 
detectable IgM.  Because IgM often has much lower avidity for antigen than IgG, a 
cell bearing only surface IgG could be expected on the whole to have a higher avidity 
for antigen than cells bearing IgM. Thus, the lack of surface IgM on these primed B 
cells could aid tolerization. 
In  addition  to the  possible high avidity of the B  cells for tolerogen, the ease of 
tolerance induction may also be directed by the fact that  the B  lymphocytes being 
tolerized did  not  bear detectable surface IgD,  a  surface isotype shown  to interfere 
with tolerance induction. Neonatal spleen cells, for example, which for the most part 
lack  IgD  receptors  (13),  or adult  spleen cells stripped  of surface IgD  (14-16),  are 
tolerized  by  amounts  of highly  haptenated  TNP-conjugates  in  the  0.1-1  #g/ml 
concentration range, similar to the concentration used here to tolerize adult primed 
B  cells.  However,  others  (22)  have  reported  that  adult  cells  in  general  are  less 
tolerizable than neonatal spleen cells whether they bear IgD or not. 
Some  of the  controversy  over  the  role  of IgD  in  B  cell  tolerance  may  be  a 
consequence  of subtle  differences  in  tolerance  protocols,  or  perhaps,  of different 
methods of defining IgD-positive or -negative B cells. The method used here, depletion 
of IgD-bearing B cells by rosetting with anti-IgD-coated RBC, appeared to be highly 
sensitive, because >  60% of the spleen cells were removed, and mitogenesis by the B 
cell activator, endotoxin, was essentially eliminated, which indicates the depletion of 
the majority of the splenic B cells. The reagent may be very sensitive in the detection 
of IgD-bearing cells, because the antiserum to mouse IgD was elicited in a heterologous 
species (13). Such antiserum may recognize a  greater number of antigenic determi- 
nants and be of higher titer than that  generated within appropriate strains of mice 
(23). 
An advantage of the present model of tolerance induction using primed spleen cells 
is that  the target cell subpopulation is an IgD-negative, mature B cell. It has been 
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because the response to antigen is due predominantly to IgD-bearing cells (13, 22). 
To study the tolerizability of IgD- B cells, the small number of IgD- B cells have to 
be enriched with the cell sorter (22) or IgD  + cells must bestripped of IgD (14-16). In 
contrast, the entire response of the primed and boosted spleen cells examined in our 
study was derived from IgD- B cells.  This is not surprising in view of what is known 
about the maturation sequence of B cells defined in terms of their surface Ig receptors. 
In general, neonatal cells bear only IgM, whereas adult cells bear both IgM and IgD, 
or IgD only  (13).  After priming,  the cells retain  IgD,  but  lose IgM  and  gain  IgG 
receptors. As the cells mature in response to antigen, IgD is eventually lost, with the 
remaining cells bearing only IgG  (20).  We anticipate  future studies  using primed 
spleen cells obtained at shorter intervals after priming than in the present work, to 
follow  tolerizability  of primed  B  cells  as  they  mature  from  IgD  positive  to  IgD 
negative. 
The type of unresponsiveness or tolerance being studied here is presumed to be a 
form of receptor binding  leading either to deletion or abortion of specific B  cells. 
Active suppression by T  cells appears not to be involved, as removal of suppressor T 
cells had no effect on unresponsiveness elicited by the continuous presence of TNP- 
TGG, and spleen cells that were tolerized by preincubation with TNP-TGG did not 
suppress nontolerized cells when mixed together. Evidence suggests that continuous 
incubation with TNP conjugate induced  tolerance similar  to that  induced  by the 
preincubation,  tolerance protocol. The stringent  time  requirement  for addition  of 
conjugate relative to TNP-KLH to elicit suppression, i.e., within 4 h, strongly suggests 
that the conjugate did not compete passively with TNP-KLH for hapten-reactive B 
cells, interferring with T-B cell collaboration over the course of the antibody response. 
Competition by TNP conjugate presumably would have disrupted T-B cell coopera- 
tion  at  times later in  the  4-5-d  antibody response than  the  first  4  h.  Thus,  TNP 
conjugate  appears  to  have  inactivated  B  cells  before  their  triggering  by  antigen 
whether the primed spleen cells were cultured continually with conjugate or were 
preincubated  with  conjugate  and  washed.  Moreover,  inactivation  was  effected 
through  an active process, because preincubation with TNP-TGG at  4°C  was  not 
inhibitory, with 37°C required to induce tolerance. Thus, as a working hypothesis it 
is postulated that tolerance of primed B cells with TNP conjugate involves saturation 
of surface IgG receptors, followed by an energy-dependent inactivation of the B cell. 
Whether the B cell is deleted or aborted, through an inability to accept T  cell help, 
for example, is open to investigation. 
In contrast to the present study, others (24) have shown suppression of TNP-KLH- 
primed  and  boosted spleen  cells with TNP-TGG when  the conjugate was  present 
continually, but not when the spleen cells were preincubated and washed free of TNP- 
TGG.  However,  the  amount  of TNP-TGG  used  relative  to  the  eliciting  antigen 
concentration was 100 times that in our study, so that a passive competition between 
conjugate and antigen might have occurred. Furthermore, the failure to elicit tolerance 
by  preincubation  may  have  been  because  the  particular  spleen  cells  used  were 
relatively insusceptible to  tolerization. The primed  spleen  cells were from animals 
boosted 2-3 mo earlier, in contrast to the 2-3 w in the present study, so that the IgG 
response was significantly less than reported here and had a large IgM component. 
Finally, if the  lack of surface IgD on the  responding B  cells examined here did 
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should  lose  or  not  bear  surface  IgD,  making  them  vulnerable  to  tolerization  to 
potentially  harmful  antigens.  Perhaps  the  explanation  is  that  the  IgG  response, 
extremely dependent on primed T cells, is safeguarded against tolerance induction by 
primed T  cells;  it is known that it is difficult to tolerize B cells  with primed T  cells 
present  (3, 4, 8, 9).  Thus, only in situations where primed T  cells are absent,  as in 
unprimed  animals,  would  the  presence  of IgD  on  B  cells  be  necessary  to  avoid 
unwanted  tolerance  induction.  The  use  of haptenated-conjugates  unrelated  to  the 
carrier used  in  priming to circumvent primed  T  cells,  as  done in  this  study,  is  an 
experimental  stituation  presumably not encountered routinely in  nature.  However, 
use of primed B cells  and such conjugates may be a  convenient and useful means to 
further probe how B cells are activated or inactivated by antigen. 
Summary 
The  above  observations  demonstrated  induction  of immunological  tolerance  in 
vitro in primed IgD-, IgG  + B cells.  In these studies,  addition of trinitrophenylated 
(TNP) turkey gammaglobulin (TGG) or TNP ovalbumin conjugates suppressed the 
secondary in  vitro response in  mice primed with TNP keyhole limpet  hemocyanin 
(TNP-KLH). Suppression was not a  reflection of a  shift  in kinetics of the antibody 
response, was not dependent on suppressor T  cells,  and could only be elicited when 
conjugate was added within 4 h of addition of TNP-KLH. Moreover, preincubation 
of the primed spleen cells  with TNP-TGG for 20 h  at  37°C, followed by extensive 
washing, was as effective in inhibiting the response to TNP-KLH as when TNP-TGG 
was present  throughout the  5  d  of culture,  reflecting induction of a  tolerant  state. 
Amounts of conjugate in the concentration range that have been shown by others to 
tolerize immature or neonatal  B cells  or mature  B cells  that  have been  stripped  of 
surface IgD were sufficient to induce tolerance.  The target cells  being tolerized did 
not bear IgD, as determined by B cell depletion and blocking procedures with anti- 
IgD. Whether the lack of surface IgD on the primed cells  contributed to the relative 
ease of tolerance induction was not established  by these studies, but the advantages 
of using  primed  B  cells  to  examine  further  the  role  of surface  IgD  in  tolerance 
susceptibility was discussed. 
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